| Autor: |
Flint, E.J., Cadigan, P.J., De Giovanni, J., Lamb, P., Pentecost, B.L. |
| Zdroj: |
The Lancet; April 1982, Vol. 319 Issue: 8277 p871-874, 4p |
| Abstrakt: |
The influence of intravenous GL enzyme (hyaluronidase) on the outcome of myocardial infarction was assessed in a controlled trial among 483 patients presenting within 6 h of the onset of symptoms. There was a consistent trend towards reduced mortality throughout the period of follow-up among GL enzyme treated patients. When the fate of all patients entering the trial was considered, irrespective of final diagnosis, the reduction in mortality at 6 months (27 of 240 GL enzyme patients, 45 of 243 placebo) was statistically significant (p=0·025). |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
